1. Home
  2. DORM vs CRNX Comparison

DORM vs CRNX Comparison

Compare DORM & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dorman Products Inc.

DORM

Dorman Products Inc.

HOLD

Current Price

$112.94

Market Cap

4.0B

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$38.96

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DORM
CRNX
Founded
1978
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.9B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
DORM
CRNX
Price
$112.94
$38.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
8
Target Price
$160.25
$76.75
AVG Volume (30 Days)
185.7K
971.8K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
8.14
N/A
EPS
6.64
N/A
Revenue
$2,130,319,000.00
$1,039,000.00
Revenue This Year
$9.70
$720.10
Revenue Next Year
$4.92
$184.67
P/E Ratio
$17.01
N/A
Revenue Growth
6.03
N/A
52 Week Low
$98.45
$25.83
52 Week High
$166.88
$57.99

Technical Indicators

Market Signals
Indicator
DORM
CRNX
Relative Strength Index (RSI) 59.16 51.30
Support Level $109.98 $33.19
Resistance Level $130.01 $45.32
Average True Range (ATR) 3.13 1.47
MACD 0.59 0.00
Stochastic Oscillator 78.46 40.75

Price Performance

Historical Comparison
DORM
CRNX

About DORM Dorman Products Inc.

Dorman Products Inc is a supplier of original equipment parts for automobiles. It offers automotive and heavy-duty replacement parts, automotive hardware, brake parts, and fasteners for the automotive and heavy-duty aftermarket. The products are sold under the Dorman brand and its sub-brands OE Solutions, Help!, Conduct-Tite, Super ATV, etc., through aftermarket retailers, warehouse distributors, specialty markets, and salvage yards. The company operates through three business segments, which include Light Duty, Heavy Duty, and Specialty Vehicle. A majority of its revenue is generated from the Light Duty segment, which designs and markets replacement parts and fasteners mainly for passenger cars and light trucks. Geographically, it derives key revenue from the United States.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Share on Social Networks: